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Background
Estrogen receptor (ER) status has been used as a biomar-
ker in breast carcinomas (BC), allowing the identification
of tumors that may respond to ER antagonists or aroma-
tase inhibitors. Two previous studies by our group evaluat-
ing gene and miRNA expression profiles in BC samples
from Brazilian patients revealed 15 genes and 3 micro-
RNAs as significantly associated with BC, according to ER
status. The aim of this study was to evaluate the correla-
tion between these 3 microRNAs and ER-related genes in
BC.
Materials and methods
miRDIP algorithm was applied to select candidates
among 15 ER-related genes for transcriptional regulation
by hsa-miR-26a, hsa-miR-26b and miR-18a. Correlation
analyses were performed between transcript levels
ofERRB4, TMEM205, SUSD3, DNAJC12, RERG, SCN7A,
TBC1D9, TCEA3, THSD4, TIGD6 and miRNAs (miR-
26a, miR-26b, and miR-18a) in BC compared with nor-
mal breast samples. miRNA expression was assessed in
63 BC and 5 normal breast samples by quantitative RT-
PCR using as internal reference RNU48, RNU44 and
U47.
Results
Down-expression of miR-18a was significantly associated
with ER-positive tumors (P=0.005), while down-expres-
sion of miR-26a and miR-26b were significantly asso-
ciated with ER-negative tumors (P=0.006 and P=0.003,
respectively). Additionally, a significant negative correla-
tion was detected between overexpression of ERBB4 and
TMEM205 and underexpression of miR-18a(P<0.001;
r=-0.703 and P<0.001; r=-0.746, respectively).
Conclusions
Our preliminary results suggest thatin ER-positive tumors,
over-expression of ERBB4 (receptor tyrosine kinase) and
TMEM205 (encoding a hypothetical protein associated
with cisplatin resistance) genes could be explained by
miR-18a down-expression. Functional studies are being
conducted to confirm these findings. This study may con-
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